In Vivo CAR-T: An Integrated Framework from Preclinical Development to Clinical Bioanalysis Opportunities and Challenges in In Vivo CAR-T Development...

Targeted lipid nanoparticles (tLNPs) are advancing in vivo CAR-T therapies by facilitating the in situ generation of CAR-T effectors, offering...